Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth

Current Opinion in Cell Biology

Volumn 12, Issue 5, 2000, Pages 613-620

  Ossowski, Liliana ^a   Aguirre Ghiso, Julio A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; INTEGRIN; UROKINASE; UROKINASE RECEPTOR;

CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; HUMAN; HUMAN CELL; LEUKOCYTE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

EID: 0033824172     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00140-X     Document Type: Review

References (58)

1. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
2. The urokinase-type plasminogen activator system in cancer metastasis: A review
3. Cancer invasion and tissue remodeling, cooperation of protease systems and cell types
4. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines
5. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
6. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro
7. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor
8. Antisense targeting of the urokinase receptor blocks urokinase-dependent proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro
9. Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes
10. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598
11. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells
12. The urokinase receptor. A cell surface, regulated chemokine
13. Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction
14. Regulation of integrin function by the urokinase receptor
15. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells
16. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: Dependence on extracellular matrix components
17. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
18. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
19. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function
20. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
21. The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation
22. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo
23. Nonproteolytic role for the urokinase receptor in cellular migration in vivo
24. Intracellular transport of GPI-anchored proteins
25. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells
26. uPA, uPAR, PAl-1: Key intersection of proteolytic, adhesive and chemotactic highways?
27. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
28. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy
29. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma
30. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
31. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
32. Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells
33. Structure and function of the urokinase receptor
34. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis
35. Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains
36. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells
37. Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis
38. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand- binding site
39. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms
40. Urokinase-type Plasminogen plasminogen Activator activator Stimulates stimulates the Ras/ERK Signaling signaling Pathway pathway and MCF-7 Cell cell Migration migration by a Mechanism mechanism that Requires requires FAK, Src, and Shc: Rapid rapid dissociation of Grb2/Sos from Shc is associated with the transient phosphorylation of ERK in urokinase-treated cells
41. Role of urokinase receptor and caveolin in regulation of integrin signaling
42. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
43. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth
44. Src-dependence and pertussis-toxin sensitivity of urokinase receptor- dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
45. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence
46. Binding of urokinase-type plasminogen activator to its receptor in MCF- 7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility
47. Regulation of cell motility by mitogen-activated protein kinase
48. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells
49. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction
50. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells
51. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes
52. Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores
53. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium
54. Nonproteolytic role for the urokinase receptor in cellular migration in vivo
55. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
56. Urokinase plasminogen activator receptor (uPA-R): One potential characteristic of metastatic phenotypes in minimal residual tumor disease
57. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection
58. VLA-4(α4β1) engagement defines a novel activation pathway for β2-integrin-dependent leukocyte adhesion involving the urokinase receptor